0
0
0
0
1
2
3
$0
Is Clorox solid or fragile? The Finex Financial Health Scanner reads CLX's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $6.7B |
|---|---|
| Net income | $587.0M |
| Operating margin | 13.6% |
| Net margin | 8.7% |
| Cash and investments | $143.0M |
| Total debt | $5.1B |
| Free cash flow | $207.1M |
| Revenue growth (1 year) | -5.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.